Keyphrases
Mutation Detection
100%
Early Phase Clinical Trials
100%
Circulating Tumor DNA (ctDNA)
100%
Blood Collection
100%
Delayed Processing
40%
Clinical Setting
40%
Blood Samples
40%
Cell-free DNA (cfDNA)
40%
Fractional Abundance
40%
Tumor
40%
BRAF V600E
20%
Patient with Tumor
20%
Small Fragments
20%
Treatment Decisions
20%
Therapy Resistance
20%
Advanced Solid Tumors
20%
Plasma DNA
20%
Molecular Analysis
20%
Diagnosis Treatment
20%
Tumor DNA
20%
Cancer Patients
20%
Solid Cancer
20%
Circulating DNA
20%
Liquid Biopsy
20%
Tumor mutation Burden
20%
PIK3CA
20%
Medicine and Dentistry
Blood Sampling
100%
Clinical Trial
100%
Circulating Tumor DNA
100%
Neoplasm
80%
Cell-Free DNA
40%
Cancer
40%
Therapy Resistance
20%
Biopsy Technique
20%
Specific Tumor
20%
Edetic Acid
20%
Liquid Biopsy
20%
Malignant Neoplasm
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Clinical Trial
100%
Circulating Tumor DNA
100%
Ethylenediaminetetraacetic Acid
20%
Malignant Neoplasm
20%
Therapy Resistance
20%
Nursing and Health Professions
Circulating Tumor DNA
100%
Liquid Biopsy
20%